NCT07772622

Brief Summary

The study will include volunteer patients diagnosed with Parkinson's disease who applied to the Neurology Outpatient Clinic at SANKO University Sani Konukoğlu Application and Research Hospital. Patients who meet the inclusion criteria will be evaluated by Dr. Hakan Polat and Physiotherapist Fatma Yılmaz in the application laboratory of the Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, SANKO University. The assessment form prepared by the researchers will be completed face-to-face with the patients. First, demographic information and disease-related data (duration since Parkinson's diagnosis, disease stage, affected side, etc.) will be recorded. The Mini-BESTest will be used to evaluate balance and gait. The muscle strength of the ankle plantar flexor and dorsiflexor muscles will be assessed using a manual muscle testing device, and quality of life will be measured with the Parkinson's Disease Questionnaire-39 (PDQ-39). Since fall problems in patients may be related to balance impairments, lower limb muscle weakness, and reduced quality of life, these parameters will also be evaluated. Therefore, in this study, while examining the validity and reliability of the modified paper grip test in individuals with Parkinson's disease, its correlation with these parameters will also be investigated. Before administering the tests, participants will receive a practical explanation of how the tests are performed and will be allowed to rest prior to assessment. The tests will be administered in the following order: first, the paper grip test by Dr. Hakan Polat, followed by the Mini-BESTest, assessment of ankle plantar and dorsiflexor muscle strength, and evaluation of quality of life. One week after the initial assessment, only the paper grip test will be re-administered by Physiotherapist Fatma Yılmaz in the same environment. This approach will minimize the effect of environmental factors on the patients' performance.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 10, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 12, 2026

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 25, 2026

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 25, 2026

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 19, 2026

Completed
Last Updated

August 19, 2026

Status Verified

February 1, 2026

Enrollment Period

5 months

First QC Date

February 25, 2026

Last Update Submit

August 18, 2026

Conditions

Keywords

parkinson's diseasebalancevalidityreability

Outcome Measures

Primary Outcomes (3)

  • mini best test

    1\. Mini Best Test Description: This is one of the clinical tests used to assess walking and balance. It consists of four sub-parameters: preparatory movement, reactive postural control, sensory orientation, and dynamic walking, comprising a total of 14 items. It is a test scored out of a total of 28 points, taking an average of 10-15 minutes to complete. A high score indicates high function.

    Measured once, at baseline (Session 1)

  • Manual muscle testing device

    2\. Manual muscle testing device Description: muscle strength (right foot dorsiflexion, left foot dorsiflexion, right foot plantar flexion, left foot plantar flexion) will be measured using the Commander Echo brand manual muscle testing device. The participant will be a

    Measured once, at baseline (Session 1)

  • Enhanced Paper Grasping Test

    Description: During measurement, participants will sit in a calm environment on a chair without armrests, with their feet and knees at a 90-degree angle, and their upper limbs comfortably placed alongside their torso. This test involves

    Baseline (Session 1) and 1 week later (Session 2)

Eligibility Criteria

Age40 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

parkinson

You may qualify if:

  • Individuals who voluntarily agree to participate in the study -

You may not qualify if:

  • Individuals who have taken any medication affecting walking ability within the last month or who have experienced an orthopedic injury within the last month

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sanko Unıversıty

Gaziantep, Gaziantep, 27090, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physiotherapy and Rehabilitation Department, Assistant Professor

Study Record Dates

First Submitted

February 25, 2026

First Posted

August 19, 2026

Study Start

August 10, 2025

Primary Completion

January 12, 2026

Study Completion

June 25, 2026

Last Updated

August 19, 2026

Record last verified: 2026-02

Locations